Patents by Inventor Yves Desprez

Yves Desprez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060234273
    Abstract: A method for detection and prognosis of breast cancer and other types of cancer. The method comprises detecting expression, if any, for both an Id-1 and an Id-2 genes, or the ratio thereof, of gene products in samples of breast tissue obtained from a patient. When expressed, Id-1 gene is a prognostic indicator that breast cancer cells are invasive and metastatic, whereas Id-2 gene is a prognostic indicator that breast cancer cells are localized and noninvasive in the breast tissue.
    Type: Application
    Filed: March 27, 2006
    Publication date: October 19, 2006
    Applicants: The Regents of the University of California
    Inventors: Pierre-Yves Desprez, Judith Campisi
  • Publication number: 20060034412
    Abstract: A control cluster for a pressurized water nuclear reactor comprising a bundle of neutron-absorbing rods each of which comprises a metal tube called cladding which is sealed off by a top end plug at its top end and by a bottom end plug at its bottom end and has a support, or spider, of radiating shape to which the absorber rods are attached through their upper end plugs, characterized in that the cladding of at least some of the absorber rods is weld-free hafnium tubes, the top end plugs of the absorber rods having hafnium cladding being of titanium-based alloy and being welded to the top end part of the hafnium cladding of the absorber rod, the bottom end plugs being of massive hafnium and being welded to the bottom
    Type: Application
    Filed: June 6, 2003
    Publication date: February 16, 2006
    Inventors: Dominique Hertz, Yves Desprez
  • Publication number: 20020137064
    Abstract: A method for detection and prognosis of breast cancer and other types of cancer. The method comprises detecting expression, if any, for both an Id-1 and an Id-2 genes, or the ratio thereof, of gene products in samples of breast tissue obtained from a patient. When expressed, Id-1 gene is a prognostic indicator that breast cancer cells are invasive and metastatic, whereas Id-2 gene is a prognostic indicator that breast cancer cells are localized and noninvasive in the breast tissue.
    Type: Application
    Filed: September 14, 2001
    Publication date: September 26, 2002
    Inventors: Pierre-Yves Desprez, Judith Campisi